Skip to main content
RPG Life Sciences Limited logo

RPG Life Sciences Limited — Investor Relations & Filings

Ticker · RPGLIFE ISIN · INE105J01010 LEI · 335800O9C9JKWKXY5Y66 BSE.NS Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2024-07-17 Regulatory Filings
Country IN India
Listing BSE.NS RPGLIFE

About RPG Life Sciences Limited

https://www.rpglifesciences.com

RPG Life Sciences Limited is an integrated pharmaceutical enterprise engaged in the development, manufacturing, and marketing of a diverse range of generic and branded formulations, as well as Active Pharmaceutical Ingredients (APIs). The company operates across several therapeutic segments, including nephrology, oncology, cardiology, rheumatology, and gastroenterology. It maintains a significant presence in the immunosuppressant market, providing critical medications for transplant recipients. With a focus on research and development, the organization produces complex molecules and finished dosages that cater to both domestic and international healthcare markets. Its manufacturing facilities adhere to stringent global quality standards, enabling the supply of essential medicines to regulated and semi-regulated markets worldwide. The portfolio includes a mix of legacy brands and specialty products designed to address chronic and acute medical conditions.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is very short (397 characters) and contains a table with details about a stop transfer date, folio number, name, certificate number, distinctive number, number of shares, and reason (lost by holder). This indicates it is related to share registration or transfer restrictions, not a financial report or announcement of voting results. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is not a report publication announcement or certification. The content is about share transfer status, which is typically a regulatory or administrative filing. Given the lack of any other context, the best fit is Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit elsewhere.
2024-07-17 English
Shareholders meeting
Regulatory Filings
2024-07-16 English
Loss of Share Certificates
Major Shareholding Notification Classification · 95% confidence The document is very short (470 characters) and consists mainly of a table listing shareholders' names, folio numbers, certificate numbers, and share counts. There is no indication of financial data, management discussion, voting results, or any narrative content. The content resembles a notification of share ownership or shareholding details. Given the nature of the data, it aligns best with a Major Shareholding Notification (MRQ), which involves reporting changes or details about significant share ownership levels. There is no evidence of other report types or announcements, and the document is not a report publication or certification. Therefore, the classification is MRQ with high confidence.
2024-07-12 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a confirmation certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. It confirms securities received from depository participants for dematerialisation during the quarter ended 30th June 2024. The document is a formal certification letter addressed to the Compliance Officer/Company Secretary and does not contain financial statements or substantive financial data. It is primarily an officer certification related to regulatory compliance rather than a financial report or announcement of financial results. Therefore, according to the Certification Rule, this document should be classified as a Regulatory Filing (RNS). The document length is short (1869 characters), and it is not an announcement of a report but a certification letter.
2024-07-12 English
Board Meeting — RPG LIFE SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 19-Jul-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for…
Regulatory Filings
2024-07-12 English
Board Meeting — Financial Results
Regulatory Filings
2024-07-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.